Miroslava Vujčić

Miroslava Vujčić

Auto-generated profile, based on publicly available information

Miroslava Vujčić

Institute of Chemistry, Technology and Metallurgy, University of Belgrade, Njegoševa 12, P.O. Box 815, 11000 Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
RERabia Eshkourfu
Rabia Eshkourfu
BČBožidar Čobeljić
Božidar Čobeljić
MVMiroslava Vujčić
Miroslava Vujčić
ITIztok Turel
Iztok Turel
APAndrej Pevec
Andrej Pevec
DSDusan Sladic
Dusan Sladic

1 January 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
VMVioleta Marković
Violeta Marković
NDNevena Debeljak
Nevena Debeljak
TSTatjana Stanojkovic
Tatjana Stanojkovic
BKBranka Kolundžija
Branka Kolundžija
DSDusan Sladic
Dusan Sladic
MJMilan D. Joksović
Milan D. Joksović

16 October 2015 in RSC Advances
Verified
Journal Article
Open access
PDF file
NFNenad R Filipovic
Nenad R Filipovic
SBSnezana Bjelogrlic
Snezana Bjelogrlic
AMAleksandar Marinkovic
Aleksandar Marinkovic
TVTatjana Verbić
Tatjana Verbić
ICIlija Cvijetić
Ilija Cvijetić
Christian MULLERChristian MULLER
Christian MULLER
A new Zn(II)-based potential chemotherapeutic agent was synthesized from the ligand 2-quinolinecarboxaldehyde selenosemicarbazone (Hqasesc). Single crystal X-ray diffraction analysis showed that the Zn(II) complex consists of a cation [Zn(Hqasesc)2]2+, two perchlorate anions and one ethanol solvent molecule. The interaction of calf thymus (CT) DNA and human serum albumin (HSA) with the Zn(II) complex was explored using absorption and emission spectral methods, and also has been supported by molecular docking studies. The complex has more affinity to minor DNA groove than major, with no significant intercalation. The HSA interaction studies of the complex revealed the quenching of the intrinsic fluorescence of the HSA through a static quenching mechanism. The antitumor activity of the ligand and the complex against pancreatic adenocarcinoma cell line (AsPC-1) and acute monocytic leukemia (THP-1) cells was evaluated. Both compounds are strong concentration-dependent apoptosis inducers in THP-1 cells. While Hqasesc in AsPC-1 cells induces apoptosis only at the highest concentration, treatment with the Zn complex shows a concentration-dependent apoptotic response, where the treated cells are arrested in the G1-to-S phase accompanied with extensive activation of caspase-8 and -9. These results indicate that the ligand and Zn(II) complex display cell phenotype specific activity.

1 January 2013 in Inorganica Chimica Acta
Verified
Journal Article
Closed access
MMMilica Milenkovic
Milica Milenkovic
ABAlessia Bacchi
Alessia Bacchi
GCGiulia Cantoni
Giulia Cantoni
SRSiniša Radulović
Siniša Radulović
NGNevenka Gligorijević
Nevenka Gligorijević
KAKatarina Anđelković
Katarina Anđelković

1 October 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MMMilica Milenkovic
Milica Milenkovic
ABAlessia Bacchi
Alessia Bacchi
GCGiulia Cantoni
Giulia Cantoni
JVJovana Vilipić
Jovana Vilipić
DSDusan Sladic
Dusan Sladic
KAKatarina Anđelković
Katarina Anđelković

15 January 2015 in European Journal of Inorganic Chemistry
Verified
Journal Article
Closed access
PDF file
MRMirjana Radanović
Mirjana Radanović
Marko RodicMarko Rodic
Marko Rodic
LJLjiljana S. Jovanović
Ljiljana S. Jovanović
MJMilan D. Joksović
Milan D. Joksović
TSTatjana Stanojkovic
Tatjana Stanojkovic
Ljiljana Vojinović JešićLjiljana Vojinović Ješić
Ljiljana Vojinović Ješić